⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LXRX News
Lexicon Pharmaceuticals, Inc.
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
globenewswire.com
LXRX
Lexicon to Present Data on Effect of Kidney Function on the Long-term Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes at 19th International Conference on Advanced Technologies & Treatments for Diabetes
globenewswire.com
LXRX
Form 8-K
sec.gov
LXRX
Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates
globenewswire.com
LXRX
Chronic Kidney Disease Market Poised to Expand Significantly During Forecast Period (2025-2034) as Demand for Early Diagnosis and Novel Therapies Increases | DelveInsight
prnewswire.com
MLYS
PROK
IRON
REGN
AMGN
MAZE
LLY
JNJ
LXRX
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
globenewswire.com
LXRX
Lexicon Pharmaceuticals to Report Fourth Quarter 2025 Financial Results on March 5, 2026
globenewswire.com
LXRX
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
globenewswire.com
LXRX
Lexicon Announces Pricing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
globenewswire.com
LXRX
Lexicon Announces Proposed Public Offering of Common Stock
globenewswire.com
LXRX